Tirzepatide, a dual incretin analog, is a boon in metabolic syndrome: an editorial

Ann Med Surg (Lond). 2024 Feb 5;86(3):1249-1250. doi: 10.1097/MS9.0000000000001782. eCollection 2024 Mar.NO ABSTRACTPMID:38463093 | PMC:PMC10923294 | DOI:10.1097/MS9.0000000000001782

Source: Annals of Medicine - March 11, 2024 Category: Internal Medicine Authors: Mainak Bardhan Pooja Gokhale Priyanka Roy Tithishri Kundu Ayush Anand Source Type: research